Form 8-K for BOHAI PHARMACEUTICALS GROUP, INC.
28-Jun-2012
Entry into a Material Definitive Agreement, Financial Statement
Item 1.01 Entry Into a Material Definitive Agreement
On June 27, 2012, Bohai Pharmaceuticals Group, Inc. (the "Company") and Euro Pacific Capital, Inc. ("Euro Pacific"), acting as representative of the holders of certain 8% convertible notes, as amended, (the "Notes") issued by the Company on January 5, 2010, entered into a Third Amendment to the Notes (the "Third Amendment") to remove the limitations on Company's ability to incur debt, to incur liens or to make capital expenditures. The purpose of the Third Amendment is to provide the Company with enhanced flexibility to seek potential sources of financing for the Company.
A copy of the Third Amendment was attached hereto as Exhibit 4.1. The description of the Third Amendment is qualified in its entirety by reference to Exhibit 4.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Description
4.1 Third Amendment to the Convertible Notes, dated June 27, 2012, between
the Company and Euro Pacific, as investor representative.
